Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 353)
Posted On: 09/10/2020 9:09:23 PM
Post# of 36566
Posted By: Paul Jackson
Another excerpt from the Seeking Alpha Article - seems like we will get China deal on swine flu soon?


This valuation conservatively estimates the potential market penetration in China and also assumes that COVID-19 does not mutate and require new vaccinations year after year, like the annual flu shot. It is also likely that the Ii-Key will be used against the arising swine flu in China, although that is also not taken into account in this model.

Generex shares, calculated to be worth $5.44 based on the current anticipated licensing agreements overseas only and ignoring all other aspects of Generex's business, appear undervalued. This is based on the potential of the Ii-Key vaccine to produce royalties in Malaysia and China. However, these royalties are completely speculative and revenues could vary considerably from these forecasts, higher and lower.

https://seekingalpha.com/article/4373034-gene...ompetition













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site